Medicure (OTCMKTS:MCUJF – Get Free Report) posted its quarterly earnings data on Friday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.05), Zacks reports. Medicure had a negative return on equity of 44.34% and a negative net margin of 21.65%.The company had revenue of $5.36 million for the quarter, compared to the consensus estimate of $2.45 million.
Medicure Price Performance
Medicure stock opened at $0.92 on Friday. The business’s 50-day simple moving average is $0.77 and its 200 day simple moving average is $0.81. Medicure has a 12-month low of $0.67 and a 12-month high of $0.97. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.03. The stock has a market cap of $9.55 million, a price-to-earnings ratio of -1.95 and a beta of 0.99.
Medicure Company Profile
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Featured Stories
- Five stocks we like better than Medicure
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
- AirJoule Technologies: Short Squeeze Setup Amid Rising Risks
- MarketBeat Week in Review – 08/10 – 08/14
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
